Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel
Gilead Sciences
Gilead Sciences
Novartis
Cogent Biosciences, Inc.
Karyopharm Therapeutics Inc
Autolus Limited
AbbVie
Phoenix Children's Hospital
Orca Biosystems, Inc.
Regeneron Pharmaceuticals
Juno Therapeutics, a Subsidiary of Celgene
Novartis
Gilead Sciences
Duke University
AVM Biotechnology Inc
Kura Oncology, Inc.
Kura Oncology, Inc.